A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
- Status
- WITHDRAWN
- Phase
- N/A
Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17)
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical and Histopathologic Characteristics of BAP1 Mutations
- Status
- COMPLETED
- Phase
- N/A
Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy
- Status
- TERMINATED
- Phase
- NA
REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT
- Status
- WITHDRAWN
- Phase
- PHASE3
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy
- Status
- TERMINATED
- Phase
- PHASE2
Sunitinib Drug Levels and Outcomes in Kidney Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Imaging Correlates of Renal Cell Carcinoma Biological Features
- Status
- COMPLETED
- Phase
- NA
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
CRLX101 Plus Bevacizumab in Advanced RCC
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)
- Status
- COMPLETED
- Phase
- PHASE3
Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5
- Status
- COMPLETED
- Phase
- PHASE2